Ventas (VTR) Hisse Fiyat
Ventas Fiyat
Gelir, son 19 yılda yıllık bileşik %14,9 artarak 5,83 Md USD seviyesine ulaştı. Hisse başına kâr, son 19 yılda yıllık %4,4 geriledi. Ventas şirketinde net marj %4,3 seviyesinde bulunuyor; birkaç yıl önceki %1,3 seviyesine göre yükseldi. Ventas şu anda yaklaşık %2,37 temettü verimi sunuyor. Temettü dağıtım oranı, kârın yaklaşık %367 düzeyindedir. Temettü, son 19 yılda yıllık %1,0 artış gösterdi. Analistler 99,00 USD medyan fiyat hedefi belirliyor; bu, güncel fiyatın %22,1 üzerinde bir seviyeye işaret ediyor. 27 analistten 22 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Ventas hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Ventas iş modeli ve hisse analizi
Ventas hakkında sık sorulan sorular
Ventas Inc is a leading real estate investment trust (REIT) specializing in healthcare properties. The business model of Ventas Inc revolves around owning, operating, and acquiring a diversified portfolio of properties across the healthcare sector. Their primary focus is on leasing and managing healthcare facilities, including senior housing communities, medical offices, hospitals, and research centers. By providing essential real estate solutions to healthcare providers, Ventas Inc generates recurring rental income and long-term value for its shareholders. Through strategic investments and a commitment to innovation, Ventas Inc continues to contribute to the growth and development of the healthcare industry.
Ventas Inc is primarily active in the healthcare real estate sector.
Some of the main competitors of Ventas Inc in the market include Welltower Inc and HCP Inc.
Ventas Inc is a renowned company operating in the real estate investment trust (REIT) sector. Established in 1998 and headquartered in Chicago, Illinois, Ventas specializes in healthcare-related properties. They own and manage a diverse portfolio of premium healthcare facilities, including senior housing communities, medical office buildings, hospitals, and skilled nursing facilities. Ventas has played a pivotal role in transforming the healthcare real estate sector through its strategic acquisitions and investments. With a strong commitment to delivering exceptional care environments, Ventas Inc has become a leading name in the industry, offering investors an opportunity to participate in this thriving sector.
Some significant milestones achieved by Ventas Inc include becoming the first healthcare real estate investment trust (REIT) to be listed on the New York Stock Exchange in 1999. The company also expanded its portfolio through strategic acquisitions, such as the $7.2 billion merger with Nationwide Health Properties in 2011. Additionally, Ventas Inc consistently demonstrated strong financial performance, increasing its annual dividend for 19 consecutive years. The company's commitment to long-term growth and its focus on providing quality healthcare real estate solutions have made Ventas Inc a leader in the industry.
Ventas Inc is primarily present in the United States.
Ventas Inc represents a commitment to integrity, innovation, and excellence in the healthcare real estate industry. The company strives to enhance the lives of seniors and other patients by providing high-quality and transformative healthcare environments. With a focus on sustainable growth and generating long-term value for stakeholders, Ventas Inc employs a philosophy of collaboration, transparency, and ethical business practices. By consistently delivering innovative solutions and maintaining strong relationships with its tenants and partners, Ventas Inc continues to lead the way in the healthcare real estate sector.
Analistler şu anda Ventas hissesi için ortalama 98,85 USD hedef fiyat belirliyor (medyan: 99,00 USD); bu, son fiyata göre +21,9 % anlamına gelir. Konsensüs 27 analist notuna dayanır.
27 analist şu anda Ventas hissesini değerlendiriyor: 22 al, 5 tut, 0 sat öneriyor. 2026 için analistler Ventas şirketinin 6,94 Md USD gelir ve 0,57 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Ventas hissesi 72,63 EUR (81,07 USD) seviyesindedir.
Ventas hissesi (VTR) 7 borsada işlem görür, bunlar arasında: NYSE (VTR), London (0LO4.L), SIX (Zürich) (VEN.SW), Frankfurt (VEN.F), München (VEN.MU), Düsseldorf (VEN.DU).
Ventas Inc is a US-based company specializing in healthcare real estate investments. Its business model is based on acquiring and managing properties used by healthcare and senior living facilities. The company is divided into three business segments: Senior Housing Operating Portfolio (SHOP), Medical Office Buildings (MOB), and Life Science Properties (LSP). SHOP includes a wide range of nursing homes and elderly care facilities. Ventas Inc acquires these properties either through facility purchases or by acquiring concession contracts from operators. The company directly operates approximately 110 facilities, making SHOP its highest revenue-generating segment. The MOB segment focuses on acquiring properties used by medical facilities such as doctor's offices, laboratories, and surgical centers. These facilities are often located in complex buildings or campus-like environments and often offer services such as pharmacies, radiology, and rehabilitation. LSP focuses on the real estate needs of life science companies, including biopharmaceutical, biotechnology, and diagnostic companies. The complexity of the properties developed for life science companies requires a high level of expertise and flexibility. Ventas Inc also provides financing and capital structures for the development or acquisition of properties in the SHOP, MOB, and LSP segments. These financing offerings can be tailored to the specific needs of facilities and operators and also include partnerships with other investors. Ventas Inc strives to ensure high-quality and continuous care for patients in its healthcare market through the provision of real estate and financing. The company also emphasizes a long-term growth strategy focused on strengthening operational performance and financial metrics. Overall, Ventas Inc's business model demonstrates a consistent focus on the increasingly important healthcare industry and the needs of patients. With a wide range of real estate offerings and financing options, the company is well-positioned to drive industry growth.
beklenen'nin Ventas hasılatı 6,94 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Ventas karı 272,74 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Ventas'nin Fiyat/Kazanç (F/K) oranı şu anda 142,90'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Ventas hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Ventas'nin Fiyat/Satış (F/S) oranı şu anda 5,62'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Ventas hisse senedinin değerleme metriği olarak hizmet eder.
Ventas'nin Eulerpool Kalite Puanı 4/10'dur.
Ventas'nin ISIN'i US92276F1003'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Ventas'nin WKN'i 878380'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Ventas'nin ticker'ı VTR'dir. Ticker sembolü, Ventas hisseleri borsada işlem görmek için kullanılır.
Ventas Hissesi
Ventas Emsaller Grubu
Ventas Ticker
Ventas FIGI
Ventas'nin tüm temel göstergeleri ve derinlemesine analizi
Ventas hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Ventas şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: